Maximus (MMS) to Release Earnings on Thursday

Key Points

• Maximus is set to announce its Q3 2025 earnings on August 7th, with analysts predicting earnings of $1.39 per share and revenue of $1.29 billion.
• The company recently declared a quarterly dividend of $0.30 per share, payable on August 31st, which represents a dividend yield of 1.68%.
• Maximus's stock is currently trading at $71.25, and it has a market capitalization of $4.01 billion with institutional investors owning 97.21% of the stock.

Maximus (NYSE:MMS - Get Free Report) will likely be issuing its Q3 2025 quarterly earnings data before the market opens on Thursday, August 7th. Analysts expect Maximus to post earnings of $1.39 per share and revenue of $1.29 billion for the quarter. Maximus has set its FY 2025 guidance at 6.30-6.600 EPS.

Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The firm had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same period last year, the firm earned $1.57 EPS. The company's quarterly revenue was up 1.0% on a year-over-year basis. On average, analysts expect Maximus to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Maximus Price Performance

Shares of Maximus stock traded down $1.02 on Friday, hitting $72.84. The company's stock had a trading volume of 509,770 shares, compared to its average volume of 422,065. The company has a market capitalization of $4.10 billion, a price-to-earnings ratio of 14.48 and a beta of 0.60. Maximus has a 1 year low of $63.77 and a 1 year high of $93.94. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.84 and a current ratio of 1.84. The firm has a fifty day moving average price of $71.31 and a 200-day moving average price of $70.50.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, August 15th. Maximus's dividend payout ratio is presently 23.86%.

Insider Activity

In other news, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the sale, the director owned 14,205 shares of the company's stock, valued at $1,028,157.90. The trade was a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Maximus

Hedge funds have recently made changes to their positions in the company. Jane Street Group LLC raised its stake in Maximus by 941.2% in the 1st quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider's stock valued at $6,701,000 after purchasing an additional 88,835 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Maximus by 7.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider's stock valued at $12,321,000 after buying an additional 11,754 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Maximus by 0.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider's stock worth $2,351,000 after buying an additional 221 shares in the last quarter. Finally, Royal Bank of Canada boosted its position in Maximus by 146.2% during the first quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider's stock worth $1,345,000 after acquiring an additional 11,716 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Analyst Ratings Changes

Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.